Dr. Arnold L. Oronsky, General Partner, has been with InterWest Partners since 1994. As a Ph.D. in immunology and senior lecturer at the department of medicine at Johns Hopkins Medical School, Dr. Oronsky brings a deep understanding of oncology, infectious diseases, cardiovascular, central nervous system, metabolic diseases and vaccines to finding and investing in successful life science companies.

Currently, Dr. Oronsky serves as a member of the boards of directors for the following publicly held life science companies: Aspreva Pharmaceuticals, Corgentech Inc., Dynavax Technologies, Metabasis Therapeutics and Myogen, Inc. In addition, Dr. Oronsky serves on the boards of directors for several privately held companies, including AkaRx, Inc., Applied Genetic Technologies Corporation (AGTC), Diatos S.A., Kanisa Pharmaceuticals and MacroGenics Inc. Prior to joining InterWest, Dr. Oronsky was the vice president for discovery research for the Lederle Laboratories division of American Cyanamid Company where he directed the research for new drugs.

Dr. Oronsky holds a Ph.D. in immunology from Columbia University and has
published more than 125 articles in scientific journals.